Bud... This is a delivery system and product engineering company and Big Pharma knows it. Multiple downstream revenue opportunities - you know of some but there are way many more.
This company is a platform.
A lot of outside people swarming around this company right now... AMGN, RLS, UTRH, Hooper...
Mannkind has one marketable drug. UTHR has already committed with milestone payments. And RLS dropped some money on the table awhile back to hold their place in Mannkinds pipeline. Whose next I havent a clue.
News 
Market Data 
Discover 
